Open Access
CC BY 4.0 · Methods Inf Med 2024; 63(03/04): 097-108
DOI: 10.1055/a-2540-8166
Original Article for a Focus Theme

Harnessing Advanced Machine Learning Techniques for Microscopic Vessel Segmentation in Pulmonary Fibrosis Using Novel Hierarchical Phase-Contrast Tomography Images

Authors

  • Pardeep Vasudev

    1   Institute of Health Informatics, Faculty of Population Sciences, University College London, London, United Kingdom
    2   Centre of Medical Image Computing, University College London, London, United Kingdom
  • Mehran Azimbagirad

    2   Centre of Medical Image Computing, University College London, London, United Kingdom
  • Shahab Aslani

    2   Centre of Medical Image Computing, University College London, London, United Kingdom
  • Moucheng Xu

    2   Centre of Medical Image Computing, University College London, London, United Kingdom
  • Yufei Wang

    3   Department of Mechanical Engineering, University College London, London, United Kingdom
  • Robert Chapman

    4   Division of Medicine, University College London, London, United Kingdom
  • Hannah Coleman

    5   Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom
  • Christopher Werlein

    6   Institute of Pathology, Hannover Medical School, Hannover, Germany
  • Claire Walsh

    3   Department of Mechanical Engineering, University College London, London, United Kingdom
    5   Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom
  • Peter Lee

    3   Department of Mechanical Engineering, University College London, London, United Kingdom
  • Paul Tafforeau

    7   European Synchrotron Radiation Facility, Grenoble, France
  • Joseph Jacob

    2   Centre of Medical Image Computing, University College London, London, United Kingdom
    8   UCL Respiratory, University College London, London, United Kingdom

Funding This research was funded in whole or in part by the Wellcome Trust (209553/Z/17/Z and 227835/Z/23/Z). This project has also been made possible in part by grant number ZIF2024-009938 from the Chan Zuckerberg Initiative Foundation.

Abstract

Background Fibrotic lung disease is a progressive illness that causes scarring and ultimately respiratory failure, with irreversible damage by the time it is diagnosed on computed tomography imaging. Recent research postulates the role of the lung vasculature on the pathogenesis of the disease. With the recent development of high-resolution hierarchical phase-contrast tomography (HiP-CT), we have the potential to understand and detect changes in the lungs long before conventional imaging. However, to gain quantitative insight into vascular changes you first need to be able to segment the vessels before further downstream analysis can be conducted. Aside from this, HiP-CT generates large-volume, high-resolution data which is time-consuming and expensive to label.

Objectives This project aims to qualitatively assess the latest machine learning methods for vessel segmentation in HiP-CT data to enable label propagation as the first step for imaging biomarker discovery, with the goal to identify early-stage interstitial lung disease amenable to treatment, before fibrosis begins.

Methods Semisupervised learning (SSL) has become a growing method to tackle sparsely labeled datasets due to its leveraging of unlabeled data. In this study, we will compare two SSL methods; Seg PL, based on pseudo-labeling, and MisMatch, using consistency regularization against state-of-the-art supervised learning method, nnU-Net, on vessel segmentation in sparsely labeled lung HiP-CT data.

Results On initial experimentation, both MisMatch and SegPL showed promising performance on qualitative review. In comparison with supervised learning, both MisMatch and SegPL showed better out-of-distribution performance within the same sample (different vessel morphology and texture vessels), though supervised learning provided more consistent segmentations for well-represented labels in the limited annotations.

Conclusion Further quantitative research is required to better assess the generalizability of these findings, though they show promising first steps toward leveraging this novel data to tackle fibrotic lung disease.

Ethical Approval Statement

For the use of novel HiP-CT in this study, original ethics approval of the data was obtained at Hannover Medical School, Germany, for the use of Human tissue culture as ex vivo models for the analysis of end-stage lung disease and lung tumors on February 4, 2022, under the following ethics approval number: 10194_BO_K_2022 (Ethics Review Board Chair Prof. Dr. Bernhard Schmidt). Approval for this retrospective study was obtained from the local research ethics committees and Leeds East Research Ethics Committee: 20/YH/0120.




Publication History

Received: 19 June 2024

Accepted: 14 February 2025

Accepted Manuscript online:
18 February 2025

Article published online:
09 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany